Home Healthcare Biotechnology HERG Screening Market

HERG Screening Market Size, Share & Trends Analysis Report By Type (Gene KCNH2, Mutant KCNH2), By Ion Channel (Voltage-Gated, Ligand Gated, Others), By Applications (Antiarrhythmic, Antipsychotic, Antibiotics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR4277DR | Pages: 156
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. HERG Screening Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Gene KCNH2
    2. Mutant KCNH2
  2. HERG Screening Market, By Ion Channel 2022-2034 (USD MILLION/ Units)
    1. Voltage-Gated
    2. Ligand Gated
    3. Others
  3. HERG Screening Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Antiarrhythmic
    2. Antipsychotic
    3. Antibiotics
    4. Others
  4. Regional HERG Screening Market
    1. North America
      1. North America HERG Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Gene KCNH2
        2. Mutant KCNH2
      2. North America HERG Screening Market By Ion Channel 2022-2034 (USD MILLION/ Units)
        1. Voltage-Gated
        2. Ligand Gated
        3. Others
      3. North America HERG Screening Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Antiarrhythmic
        2. Antipsychotic
        3. Antibiotics
        4. Others
      4. U.S.
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      5. Canada
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
    2. Europe
      1. Europe HERG Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Gene KCNH2
        2. Mutant KCNH2
      2. Europe HERG Screening Market By Ion Channel 2022-2034 (USD MILLION/ Units)
        1. Voltage-Gated
        2. Ligand Gated
        3. Others
      3. Europe HERG Screening Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Antiarrhythmic
        2. Antipsychotic
        3. Antibiotics
        4. Others
      4. U.K.
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      5. Germany
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      6. France
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      7. Spain
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      8. Italy
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      9. Russia
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      10. Nordic
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      11. Benelux
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      12. Rest of Europe
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
    3. APAC
      1. APAC HERG Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Gene KCNH2
        2. Mutant KCNH2
      2. APAC HERG Screening Market By Ion Channel 2022-2034 (USD MILLION/ Units)
        1. Voltage-Gated
        2. Ligand Gated
        3. Others
      3. APAC HERG Screening Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Antiarrhythmic
        2. Antipsychotic
        3. Antibiotics
        4. Others
      4. China
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      5. Korea
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      6. Japan
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      7. India
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      8. Australia
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      9. Taiwan
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      10. South East Asia
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      11. Rest of Asia-Pacific
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
    4. Middle East and Africa
      1. Middle East and Africa HERG Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Gene KCNH2
        2. Mutant KCNH2
      2. Middle East and Africa HERG Screening Market By Ion Channel 2022-2034 (USD MILLION/ Units)
        1. Voltage-Gated
        2. Ligand Gated
        3. Others
      3. Middle East and Africa HERG Screening Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Antiarrhythmic
        2. Antipsychotic
        3. Antibiotics
        4. Others
      4. UAE
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      5. Turkey
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      6. Saudi Arabia
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      7. South Africa
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      8. Egypt
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      9. Nigeria
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      10. Rest of MEA
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
    5. LATAM
      1. LATAM HERG Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Gene KCNH2
        2. Mutant KCNH2
      2. LATAM HERG Screening Market By Ion Channel 2022-2034 (USD MILLION/ Units)
        1. Voltage-Gated
        2. Ligand Gated
        3. Others
      3. LATAM HERG Screening Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Antiarrhythmic
        2. Antipsychotic
        3. Antibiotics
        4. Others
      4. Brazil
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      5. Mexico
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      6. Argentina
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      7. Chile
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      8. Colombia
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
      9. Rest of LATAM
        1. Gene KCNH2
        2. Mutant KCNH2
        3. Voltage-Gated
        4. Ligand Gated
        5. Others
        6. Antiarrhythmic
        7. Antipsychotic
        8. Antibiotics
        9. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.